HELSINKI, Finland, March 21, 2016 -- Stora Enso Oyj received on 18 March 2016 a notification under the Chapter 9, Section 10 of the Securities Markets Act, according to which the indirect holdings of BlackRock Inc. and its funds in Stora Enso's shares have increased over the threshold of 5% on 17 March 2016.
Total positions of BlackRock, Inc. and its funds according to the notification:
| % of shares and voting rights (total of A) | % of shares and voting rights through financial instruments (total of B) | Total of both in % (A + B) | Total number of shares and voting rights of issuer | |
| Resulting situation on the date on which threshold was crossed or reached |
4.14% shares Below 5% voting rights |
0.89% shares Below 5% voting rights |
5.03% shares Below 5% voting rights |
788,619,987 shares 237,718,379 voting rights |
| Position of previous notification (if applicable) |
Below 5% shares Below 5% voting rights |
Below 5% shares Below 5% voting rights |
Below 5% shares Below 5% voting rights |
Notified details of the resulting situation on the date on which the threshold was crossed or reached:
A: Shares and voting rights
| Class/type of shares | Number of shares and voting rights | Number of shares and voting rights | % of shares and voting rights | % of shares and voting rights |
| ISIN code (if possible) | Direct (SMA 9:5) | Indirect (SMA 9:6 and 9:7) | Direct (SMA 9:5) | Indirect (SMA 9:6 and 9:7) |
| FI0009005961 |
32,687,580 shares Below 5% voting rights |
4.14% shares Below 5% voting rights |
||
| SUBTOTAL A |
32,687,580 shares Below 5% voting rights |
4.14% shares Below 5% voting rights |
B: Financial Instruments according to SMA 9:6a
| Type of financial instrument | Expiration date |
Exercise/ Conversion period |
Physical or cash settlement | Number of shares and voting rights | % of shares and voting rights |
| Securities Lent | N/A | N/A | Physical |
4,513,250 shares Below 5% voting rights |
0.57% shares Below 5% voting rights |
| CFD | N/A | N/A | Cash |
2,477,910 shares Below 5% voting rights |
0.31% shares Below 5% voting rights |
| Total Return SWAP | 22 June 2016 | N/A | Cash |
67,000 shares Below 5% voting rights |
0.00% shares Below 5% voting rights |
| SUBTOTAL B |
7,058,160 shares Below 5% voting rights |
0.89% shares Below 5% voting rights |
For further information, please contact:
Ulla Paajanen-Sainio, SVP, Investor Relations, tel. +358 2046 21242
Stora Enso is a leading provider of renewable solutions in packaging, biomaterials, wooden constructions and paper on global markets. Our aim is to replace fossil based materials by innovating and developing new products and services based on wood and other renewable materials. We employ some 26 000 people in more than 35 countries, and our sales in 2015 were EUR 10.0 billion. Stora Enso shares are listed on Nasdaq Helsinki (STEAV, STERV) and Nasdaq Stockholm (STE A, STE R). In addition, the shares are traded in the USA as ADRs (SEOAY) on the International OTCQX over-the-counter market. storaenso.com
STORA ENSO OYJ


ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 



